Oregon’s attorney general is suing six of the nation’s largest pharmaceutical companies and pharmacy benefit managers for ...
The three healthcare conglomerates control over 80% of America’s prescription drug market through their PBM subsidiaries: Optum Rx, CVS Caremark, and Evernorth Express Scripts. Their parent companies ...
S&P 500 healthcare recap: top gainers/losers plus key stories on Medicare refill costs, China GLP-1 price wars, and Molina’s Burry boost—read now.
Centene (CNC) is fairly valued, with balanced risk/reward and no compelling near-term upside or downside for holders. CNC ...
Large, publicly traded health insurers have seen stock price increases over the past 15 years, in one case exceeding 1,000%. Information that President Donald Trump appeared to be citing shows stock ...
We recently published 10 Stocks Everyone’s Discussing Amid Latest Earnings Season. American Express Company (NYSE:AXP) is one of the stocks everyone’s discussing. Josh Brown, CEO of Ritholtz Wealth ...
While we wait for the report to drop, we’re taking a look at two of Buffett’s favorite companies in Berkshire’s publicly traded portfolio: Coca-Cola KO and American Express AXP. Buffett has suggested ...
Cigna's Evernorth division is rolling out a rebate-free model for its pharmacy benefit manager, Express Scripts—meaning one of the industry's "Big Three" is moving away from the oft-criticized ...
One of the largest pharmacy benefits managers in the U.S. is overhauling how millions of its commercial members pay for drugs, in a move that should save consumers money at the pharmacy counter while ...
A Johnstown law firm is taking legal action after what it describes as an “egregious act” by Express Scripts that could impact thousands of patients in western Pennsylvania. 10/22/25 Why Mike ...
Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...
Shares of American Express Co (NYSE:AXP) are 4% higher to trade at $336.08 at last check, after the credit card giant beat top- and bottom-line estimates for the third quarter. The company also raised ...